These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1288 related articles for article (PubMed ID: 31775862)

  • 1. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.
    Cao M; Yan H; Han X; Weng L; Wei Q; Sun X; Lu W; Wei Q; Ye J; Cai X; Hu C; Yin X; Cao P
    J Immunother Cancer; 2019 Nov; 7(1):326. PubMed ID: 31775862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular HSP90α Induces MyD88-IRAK Complex-Associated IKKα/β-NF-κB/IRF3 and JAK2/TYK2-STAT-3 Signaling in Macrophages for Tumor-Promoting M2-Polarization.
    Fan CS; Chen CC; Chen LL; Chua KV; Hung HC; Hsu JT; Huang TS
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 5. Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment.
    Han X; Wei Q; Lv Y; Weng L; Huang H; Wei Q; Li M; Mao Y; Hua D; Cai X; Cao M; Cao P
    Mol Ther; 2022 Jan; 30(1):327-340. PubMed ID: 34450250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses.
    Wang YC; He F; Feng F; Liu XW; Dong GY; Qin HY; Hu XB; Zheng MH; Liang L; Feng L; Liang YM; Han H
    Cancer Res; 2010 Jun; 70(12):4840-9. PubMed ID: 20501839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression.
    Zhao J; Zhang Z; Xue Y; Wang G; Cheng Y; Pan Y; Zhao S; Hou Y
    Theranostics; 2018; 8(22):6307-6321. PubMed ID: 30613299
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhang W; Xu L; Zhang X; Xu J; Jin JO
    Front Immunol; 2023; 14():1213467. PubMed ID: 37720226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Water extract of ginseng and astragalus regulates macrophage polarization and synergistically enhances DDP's anticancer effect.
    Chen Y; Bi L; Luo H; Jiang Y; Chen F; Wang Y; Wei G; Chen W
    J Ethnopharmacol; 2019 Mar; 232():11-20. PubMed ID: 30529424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.
    Wanderley CW; Colón DF; Luiz JPM; Oliveira FF; Viacava PR; Leite CA; Pereira JA; Silva CM; Silva CR; Silva RL; Speck-Hernandez CA; Mota JM; Alves-Filho JC; Lima-Junior RC; Cunha TM; Cunha FQ
    Cancer Res; 2018 Oct; 78(20):5891-5900. PubMed ID: 30104241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyapatite nanoparticles promote TLR4 agonist-mediated anti-tumor immunity through synergically enhanced macrophage polarization.
    Wang R; Hua Y; Wu H; Wang J; Xiao YC; Chen X; Ao Q; Zeng Q; Zhu X; Zhang X
    Acta Biomater; 2023 Jul; 164():626-640. PubMed ID: 37086827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vibrio cholerae porin OmpU mediates M1-polarization of macrophages/monocytes via TLR1/TLR2 activation.
    Khan J; Sharma PK; Mukhopadhaya A
    Immunobiology; 2015 Nov; 220(11):1199-209. PubMed ID: 26093918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferumoxytol-β-glucan Inhibits Melanoma Growth via Interacting with Dectin-1 to Polarize Macrophages into M1 Phenotype.
    Liu X; Xu Y; Li Y; Pan Y; Zhao S; Hou Y
    Int J Med Sci; 2021; 18(14):3125-3139. PubMed ID: 34400883
    [No Abstract]   [Full Text] [Related]  

  • 14. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide.
    Genin M; Clement F; Fattaccioli A; Raes M; Michiels C
    BMC Cancer; 2015 Aug; 15():577. PubMed ID: 26253167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype.
    Dong H; Yang Y; Gao C; Sun H; Wang H; Hong C; Wang J; Gong F; Gao X
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
    Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
    Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1q/TNF-related protein-9 promotes macrophage polarization and improves cardiac dysfunction after myocardial infarction.
    Liu M; Yin L; Li W; Hu J; Wang H; Ye B; Tang Y; Huang C
    J Cell Physiol; 2019 Aug; 234(10):18731-18747. PubMed ID: 30953351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
    Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
    Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Li C; Pan XY; Ma M; Zhao J; Zhao F; Lv YP
    Pharm Biol; 2021 Dec; 59(1):1533-1539. PubMed ID: 34726570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanoma.
    Noonepalle SKR; Gracia-Hernandez M; Aghdam N; Berrigan M; Coulibaly H; Li X; Zevallos-Delgado C; Pletcher A; Weselman B; Palmer E; Knox T; Sotomayor E; Chiappinelli KB; Wardrop D; Horvath A; Shook BA; Lee N; Dritschilo A; Fernandes R; Musunuri K; Shibata M; Villagra A
    J Exp Clin Cancer Res; 2024 Sep; 43(1):263. PubMed ID: 39272209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.